43. Which of the following anabolic androgen derivative(s) provide(s) the least risk for developing prostate
cancer due to its modifying the testosterone structure to 19-NOR which increases its resistance to 5a-reductase?
(A) methyltesterone and fluoxymesterone
(B) 7a-methyl-19-nortesterone and tetradydrogestrione
(C) Oxandrolone and Stanozolol
(D) Danazol